PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAgile Therapeutics
Agile Therapeutics(AGRX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
TwirlaEthinyl estradiol, Levonorgestrel2020-02-142023-2039
Prostatic neoplasms
,
Breast neoplasms
,
Menorrhagia
,
Uterine hemorrhage
,
Contraception
,
Primary ovarian insufficiency
,
Amenorrhea
,
Hot flashes
,
Hypogonadism
,
Premature menopause
,
Acne vulgaris
,
Endometriosis
,
Endometrial hyperplasia
,
Menstruation disturbances
,
Female infertility
,
Folic acid deficiency
,
Megaloblastic anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ethinyl estradiol
contraception
,
headache
,
pelvic pain
Levonorgestrel
postcoital contraception
,
biological availability
,
pharmacokinetics
,
drug interactions
,
castration-resistant prostatic neoplasms
,
endometriosis
,
unplanned pregnancy
,
dysmenorrhea
,
endometrial hyperplasia
,
headache
,
pelvic pain
,
libido
,
menopause
,
contraception
,
menorrhagia
,
hemorrhage
,
healthy volunteers/patients
,
medicated intrauterine devices
,
uterine hemorrhage
,
hot flashes
,
epilepsy
,
breast neoplasms
,
intrauterine devices
,
uterine perforation
,
postmenopause
,
venous thromboembolism
,
thromboembolism
,
pregnancy
,
amenorrhea
,
microbiota
,
metagenome
,
hyperplasia
,
estrogen replacement therapy
,
osteoporosis
,
postmenopausal osteoporosis
Microgynon
hiv
,
hiv infections
,
pharmacokinetics
,
drug interactions
,
type 2 diabetes mellitus
,
therapeutic equivalency
,
multiple sclerosis
,
sclerosis
,
rheumatoid arthritis
,
arthritis
,
pharmacological phenomena
,
diabetes mellitus
,
hematologic neoplasms
,
neoplasms
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
hepatitis b
,
chronic hepatitis b
,
systemic scleroderma
,
lung diseases
,
interstitial lung diseases
,
diffuse scleroderma
,
non-small-cell lung carcinoma
,
hepatitis c
,
chronic hepatitis c
,
bipolar disorder
,
overweight
,
tuberculosis
,
dyslipidemias
,
acquired immunodeficiency syndrome
,
hiv-2
,
atopic dermatitis
,
acromegaly
,
bone density
,
metrorrhagia
,
endometrial neoplasms
,
thrombocytopenia
,
aplastic anemia
,
amenorrhea
,
menstruation disturbances
,
premenstrual syndrome
,
pituitary diseases
,
pelvic pain
,
anorexia
,
anorexia nervosa
,
migraine disorders
,
headache
,
libido
,
dysmenorrhea
,
premenstrual dysphoric disorder
,
healthy volunteers/patients
,
contraception
,
endometriosis
,
recurrence
,
hemorrhage
,
infertility
,
body weight
,
menorrhagia
,
bariatric surgery
,
postcoital contraception
,
uterine hemorrhage
,
fertility
,
contraception behavior
,
hormonal contraception
,
affect
,
venous thromboembolism
,
thrombosis
,
venous thrombosis
,
pulmonary embolism
,
embolism
,
intracranial thrombosis
,
thromboembolism
,
intracranial sinus thrombosis
Trinessa
healthy volunteers/patients
Fluoroquinolone
chronic obstructive pulmonary disease
,
asthma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use